MedPath

Improvement in Baroreflex Sensitivity in OSAS

Not Applicable
Conditions
Obstructive Sleep Apnea Syndrome
Registration Number
NCT00284037
Lead Sponsor
Nagoya University
Brief Summary

Individuals with obstructive sleep apnea syndrome (OSAS) are at high risk for cardiovascular morbidity and mortality. The effect of long-term nocturnal therapy with continuous positive airway pressure (CPAP) on daytime baroreflex sensitivity (BRS), a predictor of cardiac death, was investigated in OSAS patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • obstructive sleep apnea syndrome
Read More
Exclusion Criteria
  • diabetes mellitus, chronic obstructive lung disease, coronary or valvular heart disease, congestive heart failure, renal failure, or endocrine dysfunction. Moreover, none of them were taking b-blockers, vasodilators, or inotropic agents at the time of enrollment in the study.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Nagoya University of Health Sciences

🇯🇵

Nagoya, Japan

© Copyright 2025. All Rights Reserved by MedPath